ArticleCancers2024

Survival of Patients with Metastatic Melanoma Treated with Ipilimumab after PD-1 Inhibitors: A Single-Center Real-World Study.

Sofia Verkhovskaia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.